GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,400,000 | -5.1% | 32,161 | -5.0% | 0.10% | +12.9% |
| Q1 2022 | $1,475,000 | -0.8% | 33,866 | +0.4% | 0.08% | +2.4% |
| Q4 2021 | $1,487,000 | +35.3% | 33,726 | +17.3% | 0.08% | +22.1% |
| Q3 2021 | $1,099,000 | +17.0% | 28,760 | +21.9% | 0.07% | +19.3% |
| Q2 2021 | $939,000 | +20.7% | 23,600 | +8.3% | 0.06% | -3.4% |
| Q1 2021 | $778,000 | -12.9% | 21,795 | -10.1% | 0.06% | -3.3% |
| Q4 2020 | $893,000 | -33.3% | 24,256 | -31.7% | 0.06% | -48.7% |
| Q3 2020 | $1,338,000 | -17.7% | 35,538 | -10.9% | 0.12% | -22.7% |
| Q2 2020 | $1,626,000 | +34.5% | 39,867 | +25.0% | 0.15% | +13.2% |
| Q1 2020 | $1,209,000 | -40.0% | 31,896 | -25.6% | 0.14% | -31.7% |
| Q4 2019 | $2,016,000 | +6.7% | 42,899 | -3.3% | 0.20% | +1.0% |
| Q3 2019 | $1,889,000 | +16.3% | 44,351 | +9.3% | 0.20% | +10.7% |
| Q2 2019 | $1,624,000 | -0.1% | 40,591 | +4.2% | 0.18% | -11.9% |
| Q1 2019 | $1,625,000 | +30.3% | 38,959 | +19.4% | 0.20% | +14.8% |
| Q4 2018 | $1,247,000 | -16.0% | 32,624 | -11.7% | 0.18% | -3.8% |
| Q3 2018 | $1,484,000 | +5.9% | 36,950 | +6.3% | 0.18% | -3.7% |
| Q2 2018 | $1,401,000 | +30.9% | 34,752 | +26.8% | 0.19% | +28.4% |
| Q1 2018 | $1,070,000 | +77.2% | 27,398 | +60.9% | 0.15% | +76.2% |
| Q4 2017 | $604,000 | -42.6% | 17,024 | -34.4% | 0.08% | -46.5% |
| Q3 2017 | $1,053,000 | -5.5% | 25,943 | +0.4% | 0.16% | -17.4% |
| Q2 2017 | $1,114,000 | +8.6% | 25,842 | +6.2% | 0.19% | +2.7% |
| Q1 2017 | $1,026,000 | +67.9% | 24,336 | +53.4% | 0.18% | +54.2% |
| Q4 2016 | $611,000 | -45.8% | 15,860 | -39.3% | 0.12% | -47.4% |
| Q3 2016 | $1,127,000 | +3.1% | 26,127 | +3.7% | 0.23% | -5.8% |
| Q2 2016 | $1,093,000 | +6.4% | 25,198 | -0.5% | 0.24% | 0.0% |
| Q1 2016 | $1,027,000 | +6.4% | 25,316 | +5.8% | 0.24% | +4.8% |
| Q4 2015 | $965,000 | +19.1% | 23,919 | +13.5% | 0.23% | +11.1% |
| Q3 2015 | $810,000 | +13.4% | 21,067 | +22.9% | 0.21% | +20.9% |
| Q2 2015 | $714,000 | -23.9% | 17,146 | -15.6% | 0.17% | -24.6% |
| Q1 2015 | $938,000 | +32.1% | 20,317 | +22.2% | 0.23% | +27.4% |
| Q4 2014 | $710,000 | -13.6% | 16,623 | -7.0% | 0.18% | -21.8% |
| Q3 2014 | $822,000 | -18.5% | 17,880 | -5.1% | 0.23% | -19.6% |
| Q2 2014 | $1,008,000 | +3.1% | 18,848 | +2.9% | 0.28% | +1.8% |
| Q1 2014 | $978,000 | +3.8% | 18,309 | +3.8% | 0.28% | +4.1% |
| Q4 2013 | $942,000 | +7.2% | 17,642 | +0.6% | 0.27% | -1.8% |
| Q3 2013 | $879,000 | +7.2% | 17,535 | +6.8% | 0.27% | -4.2% |
| Q2 2013 | $820,000 | – | 16,423 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |